SCHEMBL270646

SCHEMBL270646

CCCCCCN(C=O)CC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1C P00326 2/20 0.48
ADH1A P07327 2/20 0.48
ADH4 P08319 2/20 0.48
DNM1 Q05193 3/20 0.44
TSHR P16473 3/20 0.42
EPHX1 P07099 1/20 0.39
ADH1B P00325 1/20 0.39
ADH7 P40394 1/20 0.39
THRB P10828 1/20 0.38
FAAH O00519 2/20 0.38
TRPV1 Q8NER1 1/20 0.38
MGLL Q99685 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
S1PR2 O95136 1/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
S1PR5 Q9H228 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL388595 1.00 ADH1C (0.48) ADH1CADH1AADH4DNM1TSHR
SCHEMBL11337999 1.00 ADH1C (0.48) ADH1CADH1AADH4DNM1TSHR
SCHEMBL9660235 1.00 ADH1C (0.48) ADH1CADH1AADH4DNM1TSHR
SCHEMBL303029 1.00 ADH1C (0.48) ADH1CADH1AADH4DNM1TSHR
SCHEMBL9661097 1.00 ADH1C (0.48) ADH1CADH1AADH4DNM1TSHR
SCHEMBL9661652 1.00 ADH1C (0.48) ADH1CADH1AADH4DNM1TSHR
SCHEMBL9660996 1.00 ADH1C (0.48) ADH1CADH1AADH4DNM1TSHR
SCHEMBL302861 1.00 ADH1C (0.48) ADH1CADH1AADH4DNM1TSHR
SCHEMBL59943 0.98 ADH1C (0.45) ADH1CADH1AADH4DNM1TSHR
SCHEMBL10934343 0.93 ADH1C (0.47) ADH1CADH1AADH4DNM1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4315855-A Monoazo disperse dyes containing a nitrophenyl group and a homophthalimide group BASF AKTIENGESELLSCHAFT (DE) 1982-02-16 US claimed
EP-3663286-B1 PHOTOSENSITIZER DERIVATIVES AND APPLICATION THEREOF UNIV DALIAN TECH (CN) 2023-07-12 EP disclosed
US-11504428-B2 Photosensitizer and derivatives and application thereof DALIAN UNIVERSITY OF TECHNOLOGY (CN) 2022-11-22 US disclosed
US-20210030873-A1 PHOTOSENSITIZER AND DERIVATIVES AND APPLICATION THEREOF DALIAN UNIVERSITY OF TECHNOLOGY (CN) 2021-02-04 US disclosed
EP-2478981-B1 SILVER-(CONJUGATED COMPOUND) COMPLEX SUMITOMO CHEMICAL CO (JP) 2020-12-23 EP disclosed
EP-3663286-A1 PHOTOSENSITIZER AND DERIVATIVES AND APPLICATION THEREOF Dalian University of Technology (CN) 2020-06-10 EP disclosed
WO-2020045325-A1 POLYROTAXANE, THERMALLY CURABLE COMPOSITION INCLUDING SAID POLYROTAXANE, THERMALLY CURED CROSSLINKED OBJECT, PRODUCTION METHOD FOR POLYROTAXANE, AND PRODUCTION METHOD FOR THERMALLY CURED CROSSLINKED OBJECT アドバンスト・ソフトマテリアルズ株式会社 2020-03-05 WO disclosed
EP-2955181-B1 TRICYCLIC PYRROLOPYRIDINE COMPOUND, AND JAK INHIBITOR NISSAN CHEMICAL CORP (JP) 2019-10-30 EP disclosed
CN-109641827-A The method of catalytic production formic acid and catalyst used in the process of regenerating this under low over-voltage OXFA有限公司 2019-04-16 CN disclosed
EP-2832728-B1 TRIAZINONE COMPOUND AND T-TYPE CALCIUM CHANNEL INHIBITOR NISSAN CHEMICAL IND LTD (JP) 2018-09-05 EP disclosed
US-4933355-A ALDOSE REDUCTASE INHIBITORS SANKYO COMPANY LIMITED (JP) 1990-06-12 US disclosed
EP-0337819-A1 Thiazole derivatives, their preparation and their use in the treatment of diabetes complications Sankyo Company Limited (JP) 1989-10-18 EP disclosed
US-4864021-A ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 US disclosed
EP-0323441-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-05 EP disclosed
EP-0247381-A2 5-flurorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-12-02 EP disclosed
EP-0180897-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed
US-4315855-A Monoazo disperse dyes containing a nitrophenyl group and a homophthalimide group BASF AKTIENGESELLSCHAFT (DE) 1982-02-16 US disclosed
US-4251262-A 1-Carbamoyl-1,2,4-triazole herbicidal agents THE BOOTS COMPANY LIMITED (GB) 1981-02-17 US disclosed
US-4145341-A WATER-SOLUBLE AZO DYES CONTAINING DIAMINOPYRIMIDINE COUPLER COMPONENTS BASF AKTIENGESELLSCHAFT (DE) 1979-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11504428-B2 Photosensitizer and derivatives and application thereof PPOX, HCCS, QSOX1 ADH1C 2000/4885ADH1A 1549/4885ADH4 1926/4885
US-20210030873-A1 PHOTOSENSITIZER AND DERIVATIVES AND APPLICATION THEREOF PPOX, HCCS, QSOX1 ADH1C 2000/4885ADH1A 1549/4885ADH4 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.